No Data
No Data
CryoPort Analyst Ratings
Needham Maintains Cryoport(CYRX.US) With Buy Rating, Maintains Target Price $11
CryoPort's Promising Revenue Growth and Profitability Drive Saxon's Buy Rating
Cryoport's CRYOGENE To Provide State-Of-The-Art Biorepository Services To Moffitt Cancer Center Via Strategic Collaboration
Express News | Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
Cryoport (NASDAQ:CYRX) Adds US$51m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 81%